Get started
SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

No trades
See on Supercharts
Overview Financials News Discussions Technicals
Forecast
Seasonals

Price target

22.500.000.00%
The 2 analysts offering 1 year price forecasts for 0QN1 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to 0QN1 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Frequently Asked Questions


In the next quarter SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue is expected to reach ‪13.70 M‬ CHF. Check out SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue and earnings and make informed decisions.
According to analysts, 0QN1 price target is 22.50 CHF with a max estimate of 25.00 CHF and a min estimate of 20.00 CHF. Check if this forecast comes true in a year, meanwhile watch SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) stock price chart and keep track of the current situation with 0QN1 news and stock market news.